Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Publication Date:
      2020
    • Collection:
      Université de Genève: Archive ouverte UNIGE
    • Abstract:
      Multiple biologic and targeted synthetic disease-modifying rheumatic drugs (b/tsDMARDs) are approved for the management of rheumatoid arthritis (RA), including TNF inhibitors (TNFi), bDMARDs with other modes of action (bDMARD-OMA) and Janus kinase inhibitors (JAKi). Combination of b/tsDMARDs with conventional synthetic DMARDs (csDMARDs) is recommended, yet monotherapy is common in practice.
    • Relation:
      info:eu-repo/semantics/altIdentifier/pmid/32385143; https://archive-ouverte.unige.ch/unige:157740; unige:157740
    • Online Access:
      https://archive-ouverte.unige.ch/unige:157740
    • Rights:
      info:eu-repo/semantics/openAccess
    • Accession Number:
      edsbas.FE3441D1